Vipirinin, a coumarin-based HIV-1 Vpr inhibitor, interacts with a hydrophobic region of Vpr

92Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The human immunodeficiency virus 1 (HIV-1) viral protein R (Vpr) is an accessory protein that has been shown to have multiple roles in HIV-1 pathogenesis. By screening chemical libraries in the RIKEN Natural Products Depository, we identified a 3-phenyl coumarin-based compound that inhibited the cell cycle arrest activity of Vpr in yeast and Vpr-dependent viral infection of human macrophages. We determined its minimal pharmacophore through a structure-activity relationship study and produced more potent derivatives.Wedetected direct binding, and by assaying a panelof Vpr mutants,wefound the hydrophobic region about residues Glu-25 and Gln-65 to be potentially involved in the binding of the inhibitor. Our findings exposed a targeting site on Vpr and delineated a convenient approach to explore other targeting sites on the protein using small molecule inhibitors as bioprobes. © 2011 by The American Society for Biochemistry and Molecular Biology, Inc.

Cite

CITATION STYLE

APA

Ong, E. B. B., Watanabe, N., Saito, A., Futamura, Y., Abd El Galil, K. H., Koito, A., … Osada, H. (2011). Vipirinin, a coumarin-based HIV-1 Vpr inhibitor, interacts with a hydrophobic region of Vpr. Journal of Biological Chemistry, 286(16), 14049–14056. https://doi.org/10.1074/jbc.M110.185397

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free